# Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors

> **NCT06115005** · PHASE2 · UNKNOWN · sponsor: **Minia University** · enrollment: 40 (estimated)

## Conditions studied

- Macular Holes

## Interventions

- **BIOLOGICAL:** Plasma rich in growth factors ( PRGF )

## Key facts

- **NCT ID:** NCT06115005
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-08-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06115005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06115005, "Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06115005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*